Repare Therapeutics (RPTX) Stock Statistics & Valuation Metrics

Repare Therapeutics has a market cap or net worth of $64.77M. The enterprise value is -$15.31M.

Repare Therapeutics has 42,891,403 shares outstanding. The number of shares has decreased by -2.65% in one year.

Repare Therapeutics’s return on equity (ROE) is -0.56 and return on invested capital (ROIC) is -61.42%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Repare Therapeutics had revenue of 53.48M and earned -84.69M in profits. Earnings per share was -2.00.

In the last 12 months, operating cash flow was 2.85M and capital expenditures -80.00K, giving a free cash flow of 2.77M billion.

Repare Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Repare Therapeutics upcoming earnings date is Aug 6, 2025, After Close (Confirmed).

Repare Therapeutics as a current ratio of 6.77, with Debt / Equity ratio of 1.10%

In the past 12 months, Repare Therapeutics has paid 1.44M in taxes.

Repare Therapeutics EV to EBITDA ratio is 0.29, with an EV/FCF ratio of 0.36.

Repare Therapeutics has $124.23M in cash and marketable securities with $1.37M in debt, giving a net cash position of -$122.86M billion.

Gross margin is 99.04%, with operating margin of -174.88%, and net profit margin of -158.37%.

The average price target for Repare Therapeutics is $1.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy